La historia de Big Pharma - Bayer (IG Farben), la FDA y el virus del SIDA
Bayer pagó cientos de millones de dólares para poner fin a un escándalo de tres décadas en el que la empresa vendió sangre contaminada con VIH a hemofílicos, miles de los cuales murieron posteriormente de sida.
Milos Pokimica
Escrito por: Milos Pokimica
Revisado Médicamente Por: Dr. Xiùying Wáng, M.D.
Actualizado el 4 de agosto de 2023La ciencia de la nutrición explicó hace décadas todas las conexiones entre las enfermedades de la opulencia y el consumo de alimentos de origen animal. La mayoría de nuestros asesinos número uno se pueden prevenir, pero no hay ningún interés en cambiar la actual línea de negocio. Toda la ciencia disponible se mantendrá al margen del público y, en realidad, no importa.
Lo que la mayoría de la gente conoce no es más que propaganda. Los médicos son buenos, tienen que hacer un juramento hipocrático, están ahí para curarte y ayudarte y, por supuesto, algún día la medicina nos librará de todas las enfermedades. Normalmente, cuando la gente se enfrenta a la verdadera historia que hay detrás de las grandes farmacéuticas y se da cuenta de la verdad que government itself has a network for suppressing the science and that individual men’s interest is not its primary goal, suelen decir que todo eso pertenece al pasado. Hoy tenemos más democracia y libertades con un mejor control gubernamental, etcétera.
La respuesta es no. Tenemos incluso menos libertades que después de la Segunda Guerra Mundial. Nos han lavado el cerebro en las escuelas y a través de los medios de comunicación impregnados de investigación psicológica para el control social, pero nada más es diferente. La misma estructura existe y ha existido no sólo desde la edad media, sino incluso antes.
I will give one more recent example. You’d probably never know that Bayer (IG Farben) paid “tens of millions” of dollars to end a three-decade-long scandal in which the company sold HIV-contaminated blood products to hemophiliacs, thousands of whom later died of AIDS. Bayer is eventually forced into signing checks to individuals that acquired AIDS because, in the 1980s, the Cutter Biological section of Bayer neglected federal law and recruited gay men with high risk and intravenous drug users, and prisoners as donors of the blood that Cutter later used to produce Factor VIII and IX. It is a drug, the clotting product, that hemophiliacs need in order to not bleed to death. In 1997 Bayer was sentenced to pay 600 million into a compensation fund for hemophiliacs with HIV. About 20,000 individuals caught HIV from the blood.
Ironically, Bayer’s new hemophilia iPhone app got some coverage, as did Bayer’s hemophilia research grant to the University of Florida.
El 16 de julio de 1982, los Centros para el Control y la Prevención de Enfermedades (CDC) de Estados Unidos sugirieron que tres hemofílicos habían contraído el SIDA. Los epidemiólogos empezaron a pensar que el virus se propagaba a través de la medicación que los hemofílicos se inyectaban una vez a la semana. La medicación se elaboraba a partir de grandes reservas de plasma donado por diferentes personas. Gran parte del cual se recogía antes de la prueba obligatoria del VIH, a menudo de homosexuales y consumidores de drogas y en algunas prisiones. Sin una prueba de infección, no tenían forma de determinar si los donantes de plasma eran portadores del virus. En enero de 1983, el director del departamento biológico Cutter de Bayer confirmó en una carta que:
“There is strong evidence to suggest that AIDS is passed on to other people through … plasma products.”
These letters surfaced in trials and were found by some of the investigative journalists that later broke the story public. By May 1983, a Cutter competitor started producing a heat-treated concentrate that killed the virus, so France for example, and many other countries decided to halt all clotting concentrate imports. Cutter worried about losing consumers, so according to an enclosed memo: “want to give the impression that we continue improving our product without telling them that soon we were also going to have a heat-treated” concentrate. By June 1983, a Cutter letter to distributors to 20 countries said that:
“AIDS has become the center of irrational response in many countries” and that “This is of particular concern to us because of unsubstantiated speculations that certain blood products may transmit this syndrome.”
They lied, and many countries were still using an old concentrate. In February 1984, Cutter became the last of the four major blood product companies to get US approval to sell heated concentrate. They waited as long as possible. Still even after Cutter started to sell the new product, still for several more months, they continued making the old medicine. The reason was that the corporation had several fixed-price contracts and thought that the old product would be cheaper to produce. Bayer officials (responding on behalf of Cutter) responded with another lie: “because some customers doubted the new drug’s effectiveness,” some nations were slow to support registration of the new drug. Then they lied by telling that they had a shortage of plasma, which is used to make the medicine. For example, Taiwan was one country that still received the old HIV-infected drug. Hsu Chien-wen, an official at Taiwan’s health department, told in 2003 that Cutter had not appealed for approval to sell the heated medicine until July 1985. That was for an entire year and a half after doing so in the United States. In Hong Kong, for example, Cutter did not even need approval but only an import license in the 1980s to be able to import and sell the newer product in which normally takes one week. A company meeting notes that:
“There is excess inventory,”
que, en realidad, produjo la resolución de la empresa:
“Review international markets again to determine if more of this product can be sold.”
Because of the lack of control and corruption Cutter decided to dispose of stockpiles of older HIV-positive drugs to third world countries while selling the new, safer product in the West. If some of the people catch AIDS well, they can take Aspirin for pain. And of course, there are all third world countries, so it is going to go well with eugenic programs of depopulation of the planet. When hemophiliacs in Hong Kong all of the sudden start to test positive for HIV, local physicians raised the question of whether Cutter was dumping “AIDS tainted” medicine into less-developed countries. Cutter rejected the accusation, insisting that older drug had “no severe hazard risk” and was, in fact, the “same fine product we have supplied for years.” Hong Kong did not believe the lie, and when the local distributor asked for the newer product, Cutter responded that all of the new product was going to the US and Europe. For Hong Kong, and other third-world countries they could make an exception for a small amount for the “most vocal patients.” Meaning influential people that could potentially make a problem for them. So if you are a son of a politician, they will give you new safe stuff.
La Administración de Alimentos y Medicamentos de Estados Unidos contribuyó a que la noticia no trascendiera a la opinión pública. Government is not there to protect you and never had been. In May 1985, the FDA’s regulator of blood products, Harry M. Meyer Jr., considering the companies had violated a voluntary arrangement to remove the old drug from the market, called directors of the corporations and directed them to comply. Cutter’s internal notes from their meeting show that Meyer required that the issue is:
“Quietly solved without alerting the Congress, the medical community and the public”
also noted that the FDA wanted the matter solved “quickly and quietly.” Also at that time, Cutter official wrote that:
“It appears there are no longer any markets in the Far East where we can expect to sell substantial quantities of nonheated-treated medicine.”
They sell AIDS-tainted medicine as long as possible with no empathy. The effects of all of this are impossible to calculate because there was no test for HIV, so we do not know how many people were infected with HIV before Cutter began selling its safer medicine or afterward. Cutter also sold the old medicine in Argentina, Indonesia, Japan, Malaysia, and Singapore after February 1984. Cutter shipped more than 100,000 vials of unheated concentrate, worth more than $4 million after it began selling the safer product. The sales continued partly because of Cutter’s desire to deplete stocks of the older medicine, and partly because of fixed-price contracts, for which the company believed the older product would be cheaper to make. U.S. Justice Department had never investigated any corporate executives. Bayer in the past even marketed heroin for children. That is the level of psychopathic nature of these people.
Referencias:
Pasajes seleccionados de un libro: Pokimica, Milos. ¿Te haces vegano? Revisión de la Ciencia Parte 2. Kindle ed., Amazon, 2018.
- McHenry L, Khoshnood M. Blood money: Bayer’s inventory of HIV-contaminated blood products and third world hemophiliacs. Account Res. 2014;21(6):389-400. doi: 10.1080/08989621.2014.882780. PMID: 24785997.
- Josefson D. Haemophilia patients launch action against Bayer over contaminated blood products. BMJ. 2003 Jun 14;326(7402):1286. doi: 10.1136/bmj.326.7402.1286-g. PMID: 12805147; PMCID: PMC1151015.
Contenidos Relacionados
¿Tienes alguna duda acerca de la nutrición y la salud?
Me encantaría saber de usted y responderlas en mi próxima publicación. Agradezco sus aportes y opiniones y espero tener noticias suyas pronto. También te invito a síguenos en Facebook, Instagram y Pinterest para más contenidos sobre dieta, nutrición y salud. Puedes dejar un comentario allí y conectar con otros entusiastas de la salud, compartir tus consejos y experiencias, y recibir apoyo y ánimo de nuestro equipo y nuestra comunidad.
Espero que este post le haya resultado informativo y ameno y que esté preparado para aplicar los conocimientos adquiridos. Si le ha resultado útil, por favor compártelo con tus amigos y familiares que también podrían beneficiarse de ella. Nunca se sabe quién puede necesitar orientación y apoyo en su camino hacia la salud.
– También Te Puede Interesar –

Aprenda Sobre Nutricion
Milos Pokimica es doctor en medicina natural, nutricionista clínico, escritor sobre salud médica y nutrición y asesor en ciencias de la nutrición. Autor de la serie de libros Go Vegan? Revisión de la Ciencia, también dirige el sitio web sobre salud natural GoVeganWay.com.
Descargo De Responsabilidad Médica
GoVeganWay.com le ofrece reseñas de las últimas investigaciones relacionadas con la nutrición y la salud. La información proporcionada representa la opinión personal del autor y no pretende ni implica sustituir el asesoramiento, diagnóstico o tratamiento médico profesional. La información proporcionada tiene fines informativos únicamente y no pretende sustituir la consulta, el diagnóstico y/o el tratamiento médico de un médico o proveedor de atención médica calificado.NUNCA ignore el CONSEJO MÉDICO PROFESIONAL O RETRASAR la BÚSQUEDA de TRATAMIENTO MÉDICO a CAUSA DE ALGO QUE HAYA LEÍDO EN O accesibles a TRAVÉS de GoVeganWay.com
NUNCA APLICAR CUALQUIER cambio de ESTILO de vida O CAMBIOS EN su totalidad COMO UNA CONSECUENCIA DE ALGO QUE HA LEÍDO EN GoVeganWay.com ANTES de CONSULTAR con LICENCIA PROFESIONAL MÉDICO.
En el caso de una emergencia médica, llame a un médico o al 911 inmediatamente. GoVeganWay.com no se recomienda ni aprueba ninguna de los grupos, las organizaciones, las pruebas, los médicos, productos, procedimientos, opiniones u otra información que pueda ser mencionado en el interior.
Selecciones del editor –
Milos Pokimica es doctor en medicina natural, nutricionista clínico, escritor sobre salud médica y nutrición y asesor en ciencias de la nutrición. Autor de la serie de libros Go Vegan? Revisión de la Ciencia, también dirige el sitio web sobre salud natural GoVeganWay.com.
Últimos artículos -
Planta De Noticias Basado En
-
Plant-Based Diets May Cut Cancer Risk By A Quarter, Study Shows
on agosto 12, 2025
-
New Report Details ‘Invisible Tsunami’ Of Pervasive Chemical Toxicity
on agosto 12, 2025
-
Olive Paste Pasta Salad
on agosto 12, 2025
-
Price Drop and Familiar Recipes Boost Consumer Interest In Vegan Eggs, Study Finds
on agosto 12, 2025
-
Vegans Raise £6,000 For Farming Mental Health Charity
on agosto 11, 2025
-
How To Make This ‘Snow White Rind’ Plant-Based Cheese
on agosto 11, 2025
-
Don’t Eat Avocados Until You Do This Hack
on agosto 11, 2025
Top Noticias De Salud — ScienceDaily
- The hidden mental health danger in today’s high-THC cannabison agosto 12, 2025
THC levels in cannabis have soared in recent years, raising the risk of psychosis—especially in young, frequent users. Studies reveal a strong connection between cannabis-induced psychosis and schizophrenia, making early cessation and treatment essential.
- Scientists detect virus traces in blood that may unlock long COVID’s mysteryon agosto 12, 2025
Scientists have found protein fragments from the COVID-19 virus hidden inside tiny cellular packages in the blood of long COVID patients, offering the first potential measurable biomarker for the condition. The discovery suggests the virus may persist in body tissues long after infection, possibly explaining ongoing symptoms. While promising, the signals were subtle and inconsistent, leaving unanswered questions about whether these fragments come from lingering viral reservoirs or active […]
- Scientists discover the pancake secret that makes vegan eggs irresistibleon agosto 12, 2025
A study finds that people are more open to plant-based eggs when they’re part of familiar foods, like pancakes, rather than served plain. While taste and appearance still favor regular eggs, vegan eggs score higher on environmental and ethical benefits. Familiarity is the key to getting people to try them.
- Cutting sugar won’t curb your sweet tooth, scientists sayon agosto 12, 2025
A six-month randomized trial challenges the idea that eating more sweet foods increases a person’s preference for sweetness. Participants on diets with high, low, or mixed sweetness levels showed no changes in their sweet taste preferences, energy intake, body weight, or health markers. The study’s rigorous design suggests sweetness alone isn’t to blame for overeating, and even after the intervention, participants naturally returned to their baseline sweet intake.
- Scientists discover brain layers that get stronger with ageon agosto 12, 2025
Researchers have discovered that parts of the human brain age more slowly than previously thought—particularly in the region that processes touch. By using ultra-high-resolution brain scans, they found that while some layers of the cerebral cortex thin with age, others remain stable or even grow thicker, suggesting remarkable adaptability. This layered resilience could explain why certain skills endure into old age, while others fade, and even reveals built-in compensatory mechanisms that […]
- Scientists reversed memory loss by powering the brain’s tiny engineson agosto 12, 2025
Scientists have discovered a direct cause-and-effect link between faulty mitochondria and the memory loss seen in neurodegenerative diseases. By creating a novel tool to boost mitochondrial activity in mouse models, researchers restored memory performance, suggesting mitochondria could be a powerful new target for treatments. The findings not only shed light on the early drivers of brain cell degeneration but also open possibilities for slowing or even preventing diseases like Alzheimer’s.
- The parasite that turns off your body’s pain alarm and sneaks inon agosto 12, 2025
Scientists have discovered a parasite that can sneak into your skin without you feeling a thing. The worm, Schistosoma mansoni, has evolved a way to switch off the body’s pain and itch signals, letting it invade undetected. By blocking certain nerve pathways, it avoids triggering the immune system’s alarms. This stealth tactic not only helps the worm survive, but could inspire new kinds of pain treatments and even preventative creams to protect people from infection.
PubMed, #Dieta vegana –
- Plant-based diets and risk of type 2 diabetes: systematic review and dose-response meta-analysison agosto 11, 2025
Type 2 diabetes (T2D) incidence has been steadily increasing over the past few decades. Several studies have evaluated the effect of plant-based, vegetarian or vegan diets on the risk of T2D, although their potential benefits need to be confirmed and characterized. We performed a literature search up to July 10, 2025 using the terms/keywords related to plant-based index (PDI), vegetarian/vegan diets, and T2D. We included observational non-experimental studies evaluating adherence to such […]
- Evaluating nutritional and food cost assessments: cash-register receipts may be an alternative for FFQs – accuracy and feasibility in a dietary studyon agosto 7, 2025
CONCLUSIONS AND IMPLICATIONS: The dietary cost of the ‘FFQ-and-supermarket-prices’ method is more strongly correlated and agreeable with the ‘cash-register-receipts-items’ method when ‘eating-away-from-home’ items are omitted, indicating that ‘eating-away-from-home’ costs are poorly estimated when using the standard ‘FFQ-and-supermarket-prices’ method. Finally, estimating energy, carbohydrates, protein, fat, calcium and iron using ‘cash-register-receipts-items’ is feasible.
- Impact of healthy and sustainable diets on the mortality burden from cardiometabolic diseases and colorectal cancer in Mexican adults: a modeling studyon agosto 6, 2025
CONCLUSIONS: These findings support the implementation of policies promoting HSDs in Mexico to reduce the burden of cardiometabolic and CRC mortality. Particularly, the MHSDG is a relevant strategy due to its food-system approach, local applicability and cultural alignment.
- Resolution of Chronic Urticaria in a Vegan Patient With Vitamin B12 Supplementation: A Case Reporton agosto 4, 2025
CONCLUSION: This case underscores the importance of considering vitamin B12 deficiency in the differential diagnosis of chronic urticaria, especially in patients adhering to restrictive diets. Addressing nutritional deficiencies can be a straightforward and effective approach in resolving chronic urticaria symptoms.
- Optimization of Almond Beverage Enriched with Omega-3 Fatty Acids by Adding Brown Flaxseeds (Linum usitatissimum L.) Using D-Optimal Mixing Diagram Methodon julio 30, 2025
RESEARCH BACKGROUND: The almond beverage enriched with flaxseed is an important source of α-linolenic acid (ALA), an essential omega-3 fatty acid that the human body cannot synthesize and must obtain it through the diet. Although omega-3 fatty acids are essential for all people, this beverage is particularly beneficial for those who do not consume fish, such as vegans and vegetarians, as it is a plant-based source of ALA. Its versatility allows it to be easily incorporated into different […]
Publicaciones aleatorias –
Publicaciones destacadas -

La última versión desde PubMed, #Dieta basada en plantas –
- Probiotics and Diet Modifications: A Holistic Approach to Tackling Helicobacter pylori with the Help of the Gut Microbiotapor Tamer A Addissouky on agosto 12, 2025
CONCLUSION: The gut microbiota represents a promising target for enhancing H. pylori eradication. Further research on microbiota-modulating therapies like probiotics, diet, and lifestyle changes may help develop more effective, personalized treatment approaches.
- Associations of macronutrient intake patterns with accelerated biological ageing and life expectancy: Evidence from a population-based study in the UK Biobankpor Peng Wang on agosto 12, 2025
CONCLUSIONS: This study demonstrates that the quality of macronutrient intake patterns may be more important than overall patterns in influencing biological aging and life expectancy.
- Adherence to dietary approaches to stop hypertension (DASH), Mediterranean diet, and plant-based dietary pattern with systolic and diastolic blood pressure: A cross-sectional analysispor Zahra Hassanzadeh-Rostami on agosto 11, 2025
CONCLUSION: No significant associations could be found between DASH, Mediterranean, and healthy or unhealthy plant-based dietary index, and blood pressure levels among hypertensive individuals.
- A simple, fast and inexpensive approach using E. coli to detect and estimate vitamin B12 content in microbial extractspor Katarzyna Hencel on agosto 11, 2025
Vitamin B12 is an essential micronutrient produced only by prokaryotes, and animals must acquire it from their diet. Vitamin B12 is critical for the synthesis of methionine and propionyl-CoA metabolism. In humans, vitamin B12 deficiency has been linked to many disorders, including infertility and developmental abnormalities. The growing trend towards plant-based diets and the ageing populations increases the risk of vitamin B12 deficiency, and therefore, there is an increasing interest in…
- Plant-based diets and risk of type 2 diabetes: systematic review and dose-response meta-analysispor Alberto Murciano on agosto 11, 2025
Type 2 diabetes (T2D) incidence has been steadily increasing over the past few decades. Several studies have evaluated the effect of plant-based, vegetarian or vegan diets on the risk of T2D, although their potential benefits need to be confirmed and characterized. We performed a literature search up to July 10, 2025 using the terms/keywords related to plant-based index (PDI), vegetarian/vegan diets, and T2D. We included observational non-experimental studies evaluating adherence to such […]
- Authentication Methods for Phytochemicals (Botanicals) in Plant Extracts and Dietary Supplementspor Santhosh Kumar J Urumarudappa on agosto 10, 2025
Demand for high-quality and standardized phytochemicals (botanicals) and plant extracts if rising in both the food and dietary supplement industries. Ensuring the authenticity of the plant raw materials used in botanical and dietary supplement manufacturing is an important step before processing raw materials. However, authenticating phytochemicals (botanicals) are challenging due to their unique characteristics, including geographical location, seasonal variations, environmental conditions, […]